SARM1 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS
申请人:[en]SENYA PHARMACEUTICALS, INC.
公开号:WO2024123967A1
公开(公告)日:2024-06-13
Provided herein are SARM1 inhibitors, for example, a compound of Formula (I), and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a SARM1-mediated disorder, disease, or condition.
Synthesis of 2-Azabicyclo[4.1.0]heptanes through Stereoselective Cyclopropanation Reactions
作者:Irene Suárez del Villar、Ana Gradillas、Javier Pérez-Castells
DOI:10.1002/ejoc.201000863
日期:2010.10
catalysed by metal complexes. A study of the reaction conditions, stereochemical outcome and group protection is reported. The resulting bicyclic products are related to bioactive compounds. Transformation into thiolactams facilitates the separation of the different isomers obtained and the removal of the protecting group. The cyclopropanationreaction works with diverse diazo compounds.